Asma Vafadar
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Phytochemicals and Antioxidant Activities
Papers in
-
- Extracellular vesicles in disease 5
- Circular RNAs in diseases 4
- RNA Interference and Gene Delivery 2
- Advanced biosensing and bioanalysis techniques 2
-
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 5
- Co-authors
- Ahmad Movahedpour (10 shared papers)Zahra Shabaninejad (5 shared papers)Hamed Mirzaei (3 shared papers)Younes Ghasemi (4 shared papers)Amir Savardashtaki (7 shared papers)Amir Savardashtaki (14 shared papers)Alimohammad Shafiee (1 shared paper)Ebrahim Razi (1 shared paper)
In The Last Decade
Asma Vafadar
25 papers receiving 618 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 265
- Biochemistry 34
- Molecular Biology 391
- Drug Discovery 1
- Molecular Medicine 27
Countries citing papers authored by Asma Vafadar
This map shows the geographic impact of Asma Vafadar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asma Vafadar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asma Vafadar more than expected).
Fields of papers citing papers by Asma Vafadar
This network shows the impact of papers produced by Asma Vafadar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asma Vafadar. The network helps show where Asma Vafadar may publish in the future.
Co-authors
The 25 scholars most cited alongside Asma Vafadar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 222 | |
| 2 | 2019 | 114 | |
| 3 | 2019 | 111 | |
| 4 | 2021 | 29 | |
| 5 | 2023 | 22 | |
| 6 | 2024 | 13 | |
| 7 | 2019 | 13 | |
| 8 | 2020 | 13 | |
| 9 | 2020 | 13 | |
| 10 | 2023 | 12 | |
| 11 | 2025 | 9 | |
| 12 | 2025 | 8 | |
| 13 | 2021 | 8 | |
| 14 | 2023 | 8 | |
| 15 | 2024 | 4 | |
| 16 | 2025 | 4 | |
| 17 | 2024 | 4 | |
| 18 | 2025 | 3 | |
| 19 | 2025 | 3 | |
| 20 | 2025 | 3 |
About Asma Vafadar
Asma Vafadar is a scholar working on Molecular Biology, Cancer Research, Immunology, Obstetrics and Gynecology and Radiology, Nuclear Medicine and Imaging, having authored 27 papers that have together received 624 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), Extracellular vesicles in disease (5 papers), Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers), RNA Interference and Gene Delivery (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Phagocytosis and Immune Regulation (2 papers). The work is most often cited by research in Cancer Research (265 citations), Biochemistry (34 citations), Molecular Biology (391 citations), Drug Discovery (1 citation) and Molecular Medicine (27 citations). Asma Vafadar has collaborated with scholars based in Iran, Canada and Nigeria. Frequent co-authors include Ahmad Movahedpour, Zahra Shabaninejad, Hamed Mirzaei, Younes Ghasemi, Amir Savardashtaki, Amir Savardashtaki, Alimohammad Shafiee, Ebrahim Razi, Sarah Hajighadimi and Maryam Akbari. Their work appears in journals such as Clinica Chimica Acta, Scientific Reports, Microchemical Journal, Critical Reviews in Oncology/Hematology and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.